Read more about managing constipation while on GLP-1 meds here
Companies like those developing GLP-1 companion products are exploring various approaches in this space
PMID: 10496658 Svensson J, Lall S, Dickson SL, Bengtsson BA, Rmer J, Ahnfelt-Rnne I, Ohlsson C, Jansson JO
Increased Energy : Keeps you focused and alert throughout the day
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for managing type 2 diabetes, though some are now also licensed for weight management
1 Higher doses explicitly used for weight management (Wegovy 2.4 mg) in the STEP trials showed greater weight loss of around 15% of body weight